XML 30 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 837 $ 997
Short-term investments 9 11
Accounts receivable, net 1,284 1,093
Inventories 1,172 1,187
Prepaid expenses and assets held for sale 63 67
Total current assets 3,365 3,355
Property, plant and equipment, net of accumulated depreciation of $3,547 and $3,476 2,289 2,264
Intangible assets, net of accumulated amortization of $332 and $324 1,264 1,264
Other non-current assets 550 561
Total assets 7,468 7,444
Current liabilities:    
Short-term borrowings 42 44
Accounts payable 634 604
Accrued liabilities and liabilities held for sale 506 633
Total current liabilities 1,182 1,281
Long-term debt 1,742 1,787
Other non-current liabilities 496 486
Total liabilities 3,420 3,554
Share-based payments subject to redemption 42 60
Redeemable non-controlling interests 8 7
Ingredion stockholders’ equity:    
Preferred stock — authorized 25.0 shares — $0.01 par value, none issued 0 0
Common stock — authorized 200.0 shares — $0.01 par value, 77.8 shares issued at March 31, 2025 and December 31, 2024 1 1
Additional paid-in capital 1,158 1,152
Less: Treasury stock (common stock: 13.5 and 13.3 shares at March 31, 2025 and December 31, 2024) at cost (1,393) (1,355)
Accumulated other comprehensive loss (1,025) (1,086)
Retained earnings 5,236 5,092
Total Ingredion stockholders’ equity 3,977 3,804
Non-redeemable non-controlling interests 21 19
Total stockholders’ equity 3,998 3,823
Total liabilities and stockholders’ equity $ 7,468 $ 7,444